Company news
Bloomios Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Bloomios Reports Q2 2023 Financial Results
August 29, 2023
Bloomios Appoints Kevin Henry as National Sales Director
June 8, 2023
Bloomios Reports Q1 2023 Revenue up 30% Sequentially and 84% Y/Y to $2.75 Million
May 31, 2023
Bloomios Appoints Industry Veteran, Joe Reid, as Chief Manufacturing Officer
March 26, 2023
Bloomios Engages Hybrid Financial
February 22, 2023
Bloomios Completes $23.5 Million Acquisition of Leading Gummy Manufacturer
October 27, 2022
Bloomios To Present at The 2022 LD Micro Main Event October 25-27
October 19, 2022
Bloomios to Develop and Produce New Range of Private-Label Products Utilizing, Ashwagandha, Melatonin, Kratom, Lion's Mane, Valerian Root, Reishi Mushroom and other Natural Ingredients
August 4, 2022
Bloomios to Present at the 2022 LD Micro Invitational June 7-9
May 25, 2022
Bloomios Expands Production Capacity by 300%, Setting Stage for Strong Growth in 2022
May 18, 2022
Bloomios Reports 2021 Revenue at Record $8.5 Million, up from $1.3 Million in 2020
April 19, 2022
Bloomios Selected as Exclusive Manufacturer for DRYWORLD's New Athletic Performance CBD Product Line
March 31, 2022
OTC Markets Group Welcomes New OTCQB Companies – March 21
March 21, 2022
Bloomios Engages CMA to Lead New Investor and Public Relations Campaign
March 16, 2022
Bloomios Begins Trading on OTCQB Venture Market as BLMS, as Hemp-Derived Cannabinoid Product Sales Exceed $8 million
March 15, 2022